6-KThe Wire
TAKEDA PHARMACEUTICAL CO LTD files 6-K
Filed Mar 25, 2026 · 3mo ago · Accession 0001395064-26-000100
Plain English
Takeda announced a transformation plan expected to deliver annualized gross savings of more than JPY 200 billion by FY2028, with estimated restructuring expenses of approximately JPY 150 billion in FY2026.
Filing details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Ticker
- TAK
- CIK
- 1395064
- Form type
- 6-K
- Filing date
- Mar 25, 2026
- Report date
- Mar 25, 2026
- Document
- form6k_032526.htm
- Size
- 27 KB